AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...
The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
The CMS Administrator’s job is one of the most important and challenging jobs in health care. It is my greatest hope that the ...
The Centers for Medicare & Medicaid Services (CMS) has named 14 states plus the District of Columbia to participate in the ...
A record number of Illinois residents have signed up for Affordable Care Act health insurance plans for this year — amid uncertainties about the future of tax credits that lower the cost of those ...
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.
The proposal aimed to streamline how schools bill Medicaid for the mental health and medical services they provide to ...